---
title: "LANCIANO PETER L — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e3a64bd6-9b2c-5deb-a867-ec0c320eacdd
json: https://whiteintel.dev/api/public/dossier/e3a64bd6-9b2c-5deb-a867-ec0c320eacdd
identifier: sec:0001350461
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LANCIANO PETER L

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001350461`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e3a64bd6-9b2c-5deb-a867-ec0c320eacdd  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e3a64bd6-9b2c-5deb-a867-ec0c320eacdd  

## Ownership & control

### Holdings / subsidiaries

- **ALTUS PHARMACEUTICALS INC.** (director) — https://whiteintel.dev/entity/811aa943-09a9-53f5-a4bc-198bb79c9a2f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LANCIANO PETER L**. Human view: https://whiteintel.dev/entity/e3a64bd6-9b2c-5deb-a867-ec0c320eacdd · Structured JSON: https://whiteintel.dev/api/public/dossier/e3a64bd6-9b2c-5deb-a867-ec0c320eacdd._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._